 Jack Kalavritinos |
APCO Worldwide has recruited Jack Kalavritinos, who was director for intergovernmental & external affairs at the Dept. of Health & Human Services, for a senior director slot. He will join the Washington-based firm on May 28.
At HHS, Kalavritinos guided Secretary Alex Azar on communications and outreach and promoted the department’s efforts to combat the opioid crisis, reduce drug prices and engage with healthcare providers.
Earlier, he served in the Food and Drug Administration as associate commissioner for external affairs and counselor to then- commissioner Scott Gottlieb.
Prior to joining the Trump team in 2017, Kalavritinos handled domestic and international policy issues for Covidien, which is now Medtronic, for more than seven years.
Evan Kraus, APCO’s global president, said Kalavritinos’ experience in the private and public sector will be invaluable to clients in today’s challenging health policy landscape.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
